Literature DB >> 17196689

Transcatheter closure of a non-restrictive patent ductus arteriosus with an Amplatzer muscular ventricular septal defect occluder.

Andreas Eicken, Gunter Balling, Hans Peter Gildein, Thomas Genz, Harald Kaemmerer, John Hess.   

Abstract

We report on successful occlusion of a large unrestrictive PDA in an adult patient with pulmonary hypertension.

Entities:  

Mesh：

Year:  2006        PMID： 17196689     DOI： 10.1016/j.ijcard.2006.10.023

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


  10 in total

1.  Percutaneous closure of a gigantic patent ductus arteriosus (PDA) with pulmonary hypertension with an atrial septal defect occluder in a 35-year-old woman.

Authors:  Michael Froehle; Nikolaus A Haas; Eugen Sandica; Christoph Happel; Kai Thorsten Laser
Journal:  Clin Res Cardiol       Date:  2013-12-20       Impact factor: 5.460

2.  Transcatheter closure of a large patent ductus arteriosus with severe pulmonary arterial hypertension in a child.

Authors:  C Karakurt; O Elkıran; S F Celik; G Koçak
Journal:  Herz       Date:  2013-07-18       Impact factor: 1.443

3.  Patent ductus arteriosus closure using an Amplatzer(™) ventricular septal defect closure device.

Authors:  Rajeev Fernando; Ketan Koranne; Pranav Loyalka; Biswajit Kar; Igor Gregoric
Journal:  Exp Clin Cardiol       Date:  2013

4.  Tailored circulatory intervention in adults with pulmonary hypertension due to congenital heart disease.

Authors:  L E Couperus; I R Henkens; M R M Jongbloed; M G Hazekamp; M J Schalij; H W Vliegen
Journal:  Neth Heart J       Date:  2016-04-20       Impact factor: 2.380

Review 5.  Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.

Authors:  Nazzareno Galie; Alessandra Manes; Massimiliano Palazzini; Luca Negro; Alessandro Marinelli; Simona Gambetti; Elisabetta Mariucci; Andrea Donti; Angelo Branzi; Fernando M Picchio
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 6.  Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery.

Authors:  Nathan Brunner; Vinicio A de Jesus Perez; Alice Richter; François Haddad; André Denault; Vanessa Rojas; Ke Yuan; Mark Orcholski; Xiaobo Liao
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

7.  The adult patient with eisenmenger syndrome: a medical update after dana point part I: epidemiology, clinical aspects and diagnostic options.

Authors:  Harald Kaemmerer; Siegrun Mebus; Ingram Schulze-Neick; Andreas Eicken; Pedro T Trindade; Alfred Hager; Erwin Oechslin; Koichiro Niwa; Irene Lang; John Hess
Journal:  Curr Cardiol Rev       Date:  2010-11

8.  Stepwise Approach Using Combined Management in Patients with Congenital Heart Disease and Borderline Pulmonary Vascular Disease.

Authors:  Sang-Yun Lee; Soo-Jin Kim; Jae Sung Son; Seong-Ho Kim; Chang-Ha Lee
Journal:  Korean Circ J       Date:  2015-05-08       Impact factor: 3.243

9.  Pushing the envelope: a treat and repair strategy for patients with advanced pulmonary hypertension associated with congenital heart disease.

Authors:  Rebecca Johnson Kameny; Elizabeth Colglazier; Hythem Nawaytou; Phillip Moore; V Mohan Reddy; David Teitel; Jeffrey R Fineman
Journal:  Pulm Circ       Date:  2017-09-01       Impact factor: 3.017

10.  Transcatheter Closure of Patent Ductus Arteriosus in Elderly Patients: Initial and One-Year Follow-Up Results-Do We Have the Proper Device?

Authors:  Michal Galeczka; Malgorzata Szkutnik; Jacek Bialkowski; Sebastian Smerdzinski; Mateusz Knop; Adam Sukiennik; Roland Fiszer
Journal:  J Interv Cardiol       Date:  2020-04-29       Impact factor: 2.279
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.